Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
13
CANF Quote, Financials, Valuation and Earnings
Last price:
$0.18
Seasonality move
:
-4.6%
Day range:
$0.17 - $0.20
52-week range:
$0.23 - $2.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.34x
P/B ratio:
0.61x
Volume:
1.5M
Avg. volume:
13.5M
1-year change:
-87.39%
Market cap:
$2.8M
Revenue:
$677.2K
EPS (TTM):
--
Earnings Data
Next earnings date for CANF
--
Most recent earnings per share
-$1.52
Missed by $1.15
(Mar 28/2024)
Consensus Estimate
-$0.37
(Mar 28/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CANF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2025 | Q3 | -- | -- | -- | -- | -- |
| 08/11/2025 | Q2 | -- | -- | -- | -- | -- |
| 04/14/2025 | Q1 | -- | -- | -- | -- | -- |
| 03/28/2025 | Q4 | $150K | -- | -- | -- | -- |
| 12/27/2024 | Q3 | $150K | -- | -- | -- | -- |
| 08/29/2024 | Q2 | $150K | -- | -- | -- | -- |
| 06/24/2024 | Q1 | $150K | -- | -- | -- | -- |
| 03/28/2024 | Q4 | $200K | $155K | -$1.52 | -$0.37 | -$1.15 |
| 11/30/2023 | Q3 | -- | -- | -$0.43 | -$0.43 | -$0.00 |
| 08/25/2023 | Q2 | -- | -- | -$0.40 | -$0.73 | $0.32 |
| 05/26/2023 | Q1 | -- | -- | -$0.65 | -$1.90 | $1.25 |
| 03/24/2023 | Q4 | -- | -- | -- | -$1.27 | -- |
| 11/25/2022 | Q3 | -- | -- | -$1.30 | -$1.05 | -$0.25 |
| 08/25/2022 | Q2 | -- | -- | -$0.81 | -$0.85 | $0.04 |
| 05/26/2022 | Q1 | -- | -- | -$0.90 | -$1.40 | $0.50 |
| 03/24/2022 | Q4 | -- | -- | -$3.00 | -$1.80 | -$1.20 |
| 11/26/2021 | Q3 | -- | -- | -$3.00 | -- | -- |
| 08/26/2021 | Q2 | -- | -- | -$1.84 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.16 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -- | -- | -- |
| 11/30/2020 | Q3 | -- | -- | -$1.67 | -- | -- |
| 08/27/2020 | Q2 | -- | -- | -$2.84 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$9.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$9.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$7.39 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$9.21 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$12.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$27.00 | -- | -- |
| 11/27/2018 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$9.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$15.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$15.00 | -- | -- |
| 11/27/2017 | Q3 | -- | -- | -$12.00 | -- | -- |
| 09/01/2017 | Q2 | -- | -- | -$15.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$15.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$34.07 | -- | -- |
| 11/25/2016 | Q3 | -- | -- | -$24.81 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$14.46 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$16.66 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $8.76 | -- | -- |
Can-Fite BioPharma Ltd. Earnings Questions
-
How Much did Can-Fite BioPharma Ltd. Generate in Revenue Last Quarter?
Can-Fite BioPharma Ltd. reported $155K worth of top line sales in its most recent quarter.
-
Did Can-Fite BioPharma Ltd. Beat Earnings Last Quarter?
Can-Fite BioPharma Ltd. announced earnings per share of -$1.52 which represents a miss of analyst forecast a -$0.37 per share.
-
Is Can-Fite BioPharma Ltd. Profitable?
Can-Fite BioPharma Ltd. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Can-Fite BioPharma Ltd. EPS Next Year?
Can-Fite BioPharma Ltd.'s earnings are forecast to decrease from -$1.09 per share to -$1.85 per share next year representing a decrease of -7.87%.
-
When is Can-Fite BioPharma Ltd.'s Earnings Date?
Currently, Can-Fite BioPharma Ltd. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
